. 2010 Jul 20;1(5):799–808. doi: 10.3892/etm.2010.117

Table III.

Correlation between the expression of LAT1 and other immunohistochemical markers.

Markers	Spearman γ	95% confidence interval	p-value
CD98
All cases^a (n=188)	0.7320	0.6553–0.7937	<0.0001
AC (n=123)	0.7382	0.6424–0.8113	<0.0001
SQC (n=53)	0.5347	0.3016–0.7075	<0.0001
Ki-67
All^a (n=188)	0.7342	0.6580–0.7955	<0.0001
AC (n=123)	0.6616	0.5451–0.7530	<0.0001
SQC (n=53)	0.3632	0.0948–0.5824	0.0075
VEGF
All^a (n=188)	0.1442	0.0032–0.2854	0.0484
AC (n=123)	0.2611	0.0828–0.4232	0.0035
SQC (n=53)	0.2103	−0.0718–0.4612	0.1307
CD31
All^a (n=188)	0.3073	0.1675–0.4349	<0.0001
AC (n=123)	0.3953	0.2285–0.5379	<0.0001
SQC (n=53)	0.1769	−0.1062–0.4335	0.2050
CD34
All^a (n=188)	0.3590	0.2235–0.4808	<0.0001
AC (n=123)	0.4237	0.2617–0.5625	<0.0001
SQC (n=53)	0.2288	−0.0525–0.4764	0.0994

Large-cell carcinoma was included. AC, adenocarcinoma; SQC, squamous cell carcinoma; LAT1, L-type amino acid transporter 1; VEGF, vascular endothelial growth factor.